CardioGard Medical
Emboli Protection System
Health Tech & Life Sciences
Non Active, Feb 2019 ceased to operate
Company Overview
Snapshot
Founded in January 2010, CardioGard Medical operates with 1–10 employees. The company ceased operations in February 2019.
Business overview
CardioGard Medical develops an Emboli Protection System designed for heart bypass surgeries. The core product is a double-lumen cannula system that removes gaseous and solid embolic material from the surgical field while providing oxygenated blood to the patient. This system is intended for use with existing hospital equipment, serving the healthcare market within the Medical Devices and Medical Treatment & Therapeutics sectors.
Log in to access full profile ›Company Intelligence Q&A
- What is CardioGard Medical's primary focus?
- CardioGard Medical focuses on developing an Emboli Protection System to remove gaseous and solid embolic material during heart bypass surgeries.
- When was CardioGard Medical founded?
- CardioGard Medical was founded in January 2010.
- What is the status of CardioGard Medical?
- CardioGard Medical ceased operations in February 2019.
- What technology does CardioGard Medical's system utilize?
- The system utilizes a double-lumen cannula design that controls blood flow rates to remove emboli while maintaining physiologically acceptable net blood flow into the aorta.
- Which sector does CardioGard Medical operate in?
- CardioGard Medical operates within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Medical Treatment & Therapeutics.